Nutex Health (NUTX) Competitors

Nutex Health (NASDAQ:NUTX) and NV5 Global (NASDAQ:NVEE) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, community ranking, media sentiment, dividends, risk, profitability and institutional ownership.

Is NUTX or NVEE more profitable?

NV5 Global has a net margin of 3.25% compared to Nutex Health's net margin of -14.09%. NV5 Global's return on equity of 9.34% beat Nutex Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutex Health	-14.09%	-51.27%	-9.89%
NV5 Global	3.25%	9.34%	6.02%

Which has better earnings and valuation, NUTX or NVEE?

NV5 Global has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than NV5 Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$292.00M	0.96	-$45.79M	-$9.39	-5.50
NV5 Global	$941.27M	1.33	$44.61M	$0.49	39.29

Which has more volatility & risk, NUTX or NVEE?

Nutex Health has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, NV5 Global has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500.

Does the MarketBeat Community prefer NUTX or NVEE?

NV5 Global received 280 more outperform votes than Nutex Health when rated by MarketBeat users. However, 100.00% of users gave Nutex Health an outperform vote while only 59.88% of users gave NV5 Global an outperform vote.

Company	Underperform	Outperform
Nutex Health	Outperform Votes 11 100.00%	Underperform Votes No Votes
NV5 Global	Outperform Votes 291 59.88%	Underperform Votes 195 40.12%

Do analysts prefer NUTX or NVEE?

Nutex Health currently has a consensus price target of $67.50, indicating a potential upside of 30.61%. NV5 Global has a consensus price target of $25.67, indicating a potential upside of 33.33%. Given NV5 Global's higher possible upside, analysts plainly believe NV5 Global is more favorable than Nutex Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
NV5 Global	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the media favor NUTX or NVEE?

In the previous week, NV5 Global had 13 more articles in the media than Nutex Health. MarketBeat recorded 18 mentions for NV5 Global and 5 mentions for Nutex Health. NV5 Global's average media sentiment score of 1.22 beat Nutex Health's score of 0.22 indicating that NV5 Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutex Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NV5 Global	12 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in NUTX or NVEE?

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 75.5% of NV5 Global shares are held by institutional investors. 38.5% of Nutex Health shares are held by insiders. Comparatively, 12.4% of NV5 Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

NV5 Global beats Nutex Health on 14 of the 17 factors compared between the two stocks.